Lexicon Pharmaceuticals, Inc.【LXRX】 業績推移・財務諸表

(単位:千ドル) 2Q11 3Q11 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 1Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 555 355 300 199 372 218 360 214 238 1,410 277 676 419 21,482 1,792 376 566 127,280 12,494 20,089 27,717 18,293 12,053 26,942 - 25,207 13,753 6,856 17,071 9,216 9,682 294,448 8,727 7,999 9,163 6,634 27 234 23 - - - - 317 162 1,130 1,647 1,750 1,262
売上成長率(%) - - - - - - - - - - - - - -
売上原価 - - - - - - - - - - - - - - - - - - - - - 225 537 599 - 533 838 551 - 553 1,327 577 - 568 728 633 - - - - - - - 8 7 31 166 71 30
研究開発費 20,145 19,655 23,037 19,355 19,192 - 20,327 23,692 25,400 - 23,953 21,187 24,108 - 20,865 20,769 23,111 - 37,002 48,216 52,533 43,581 26,934 39,137 - 47,783 26,589 13,769 - 12,022 12,637 26,659 - 55,181 57,301 40,147 12,609 10,257 15,682 14,926 13,356 10,557 12,026 14,541 17,558 14,372 17,643 25,780 15,303
販売管理費 - - - - - - - - - - - - - - - - - - - - - 14,871 18,475 16,724 - 14,857 - - - - - - - - - - - - - - - - - - 32,228 32,060 39,192 39,592 11,608
営業費用 26,481 26,046 29,683 25,679 29,432 - 25,915 28,838 31,454 - 30,749 26,787 40,755 - 28,319 27,064 34,243 - 46,365 57,110 62,650 60,778 45,946 56,460 - 63,173 44,182 29,899 - 26,685 28,227 69,772 - 70,437 73,742 52,777 20,866 18,193 22,985 23,417 -24,042 -23,134 -31,166 44,557 49,793 46,463 57,001 65,443 26,941
営業利益 -25,926 -25,691 -29,383 -25,480 -29,060 -24,492 -25,555 -28,624 -31,216 -16,976 -30,472 -26,111 -40,336 -3,447 -26,527 -26,688 -33,677 88,360 -33,871 -37,021 -34,933 -42,485 -33,893 -29,518 -30,785 -37,966 -30,429 -23,043 -12,367 -17,469 -18,545 224,676 -47,217 -62,438 -64,579 86,675 -20,839 -17,959 -22,962 -23,380 -24,007 -23,095 -31,142 -44,240 -49,631 -45,333 -55,354 -63,693 -25,679
営業利益率 (%) - - - - -
経常(税引前)利益 - -26,103 - - - - - - - - - - - - - - - - - - - -43,543 -35,059 -30,722 - -42,075 -34,706 -27,512 - - - 220,072 - - - 82,603 - - - - - - - - - - - - -
経常(税引前)利益率(%) - -7352.96 - - - - - - - - - - - - - - - - - - - -238.03 -290.87 -114.03 - -166.92 -252.35 -401.28 - - - 74.74 - - - 1245.15 - - - - - - - - - - - - -
法人税等合計 - 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
純利益 -26,638 -26,103 -29,868 -25,931 -29,539 -24,873 -25,974 -29,080 -31,658 -17,414 -30,835 -26,028 -40,498 -2,933 -28,076 -28,074 -35,282 - -34,883 -38,112 -36,015 -34,891 -35,059 -30,722 -28,378 -42,075 -34,706 -27,512 -16,781 -21,797 -23,018 226,086 -51,138 -66,611 -69,071 82,603 -20,958 -18,067 -23,122 -23,476 -24,587 -23,387 -31,934 -44,904 -50,525 -48,397 -53,429 -64,811 -25,295
純利益率(%) - - - - - -
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 2.13 -0.48 -0.63 -0.65 0.77 -0.15 -0.13 -0.16 -0.16 -0.16 -0.13 -0.17 -0.22 -0.21 -0.2 -0.17 -0.18 -0.07
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1.95 -0.48 -0.63 -0.65 0.71 -0.15 -0.13 -0.16 -0.16 -0.16 -0.13 -0.17 -0.22 -0.21 -0.2 -0.17 -0.18 -0.07
EBITDA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -